Cell News and Research

RSS

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.

6 Sep 2023

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

In a recent review published in Cell, a group of authors delved into the complexities of menopause, assessed its global impacts on health, and evaluated the effectiveness and safety of current treatments, emphasizing the importance of further research.

6 Sep 2023

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays.

From CN Bio 6 Sep 2023

Study reveals heart failure insights at single-cell level

Researchers examined the cell-intrinsic effects of hematopoietic stem cells with somatic mutations in circulating cells from heart failure patients.

6 Sep 2023

Review identifies future research directions for the study of a SARS-CoV-2 reservoir in PASC

Researchers reviewed the evidence for SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).

6 Sep 2023

Clovibactin - a game-changing novel antibiotic with no resistance

Researchers reported the discovery of a new antibiotic, clovibactin.

6 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Study identifies potential target for reversing drug resistance in ovarian cancer

For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin.

5 Sep 2023

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

The study reveals that Novavax's updated XBB.1.5 vaccine effectively induces cross-neutralizing antibodies against multiple Omicron XBB sub-variants in both mice and non-human primates.

5 Sep 2023

Could a new framework for aging biomarkers revolutionize how we understand and treat the aging process?

A comprehensive review in the journal Cell outlines a unified framework for classifying and validating aging biomarkers, aiming to streamline their integration into clinical research and practice. The study categorizes biomarkers into types like molecular, functional, and clinical, and sets criteria for their feasibility, validity, and applicability, all with the goal of better understanding and intervening in the aging process.

5 Sep 2023

Could medicinal plants be the key to reversing cognitive decline?

Researchers explore available evidence that medicinal plants may help improve cognitive function by reducing brain inflammation.

5 Sep 2023

OHSU scientists discover new avenue of cell death in Alzheimer's disease and vascular dementia

Researchers have discovered a new avenue of cell death in Alzheimer's disease and vascular dementia.

5 Sep 2023

Scientists develop new technique to study sugars on immune cells

Everyone loves a sweet treat, even our cells. While we typically think of sugar as a component of our diet that gives us energy, sugars are also very important in guiding the activity of our cells.

5 Sep 2023

Gut feeling: How your microbiome could be shaping your mental health

Researchers in Biological Psychiatry delve into the complex relationship between the gut microbiome and mental health disorders like depression and bipolar disorder. The study explores how not just gut bacteria, but also lesser-known gut microorganisms such as viruses, fungi, and parasites, play a pivotal role in mood disorders.

5 Sep 2023

How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

From Quantum-SI 5 Sep 2023

Sex hormones drive differences in male and female mouse kidneys

Female kidneys are known to be more resilient to disease and injury, but males need not despair. A new USC Stem Cell-led study published in Developmental Cell describes not only how sex hormones drive differences in male and female mouse kidneys, but also how lowering testosterone can "feminize" this organ and improve its resilience.

5 Sep 2023

Research shows how resistant starch could slow down progression of non-alcoholic fatty liver disease

The prebiotic resistant starch could play an important role in the treatment of non-alcoholic fatty liver disease (NAFLD) in the future.

5 Sep 2023

Global partnership aims to alleviate age-related functional declines and promote healthy aging

A global partnership led by Lancaster University will promote collaborative, multidisciplinary research that aims to alleviate the development of age-related functional declines and thus promote healthy aging.

5 Sep 2023

Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT workflows

Yourgene Health plc (“Yourgene”), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit. MagBench solution is available to Sage™ customers across Asia-Pacific and the Middle East.

From Yourgene Health 5 Sep 2023

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

From Illumina, Inc. 5 Sep 2023

Cell News and Research

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

Study reveals heart failure insights at single-cell level

Review identifies future research directions for the study of a SARS-CoV-2 reservoir in PASC

Clovibactin - a game-changing novel antibiotic with no resistance

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Study identifies potential target for reversing drug resistance in ovarian cancer

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

Could a new framework for aging biomarkers revolutionize how we understand and treat the aging process?

Could medicinal plants be the key to reversing cognitive decline?

OHSU scientists discover new avenue of cell death in Alzheimer's disease and vascular dementia

Scientists develop new technique to study sugars on immune cells

Gut feeling: How your microbiome could be shaping your mental health

How is next-generation protein sequencing democratizing protein sequencing?

Sex hormones drive differences in male and female mouse kidneys

Research shows how resistant starch could slow down progression of non-alcoholic fatty liver disease

Global partnership aims to alleviate age-related functional declines and promote healthy aging

Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT workflows

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

How to optimize your cell line development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo